Published in Women's Health Weekly, December 22nd, 1997
Currently, MedImmune has been conducting a Phase I clinical trial with its first HPV vaccine candidate, HPV-11. MedImmune expects to begin clinical evaluation of HPV-18 and HPV-16 vaccine candidates in 1998.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly